Cargando…
Metabolism, Activity, and Targeting of D-and L-2-Hydroxyglutarates
Isocitrate dehydrogenases (IDH1/2) are frequently mutated in multiple types of human cancer, resulting in neomorphic enzymes that convert α-ketoglutarate (α-KG) to 2-hydroxyglutarate (2-HG). The current view on the mechanism of IDH mutation holds that 2-HG acts as an antagonist of α-KG to competitiv...
Autores principales: | Ye, Dan, Guan, Kun-Liang, Xiong, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884165/ https://www.ncbi.nlm.nih.gov/pubmed/29458964 http://dx.doi.org/10.1016/j.trecan.2017.12.005 |
Ejemplares similares
-
The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis
por: Wang, Tian-Xiang, et al.
Publicado: (2019) -
D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth
por: Ma, Shenghong, et al.
Publicado: (2015) -
D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells
por: Ugele, Ines, et al.
Publicado: (2019) -
An interesting case of metabolic dystonia: L-2 hydroxyglutaric aciduria
por: Balaji, Padma, et al.
Publicado: (2014) -
The sodium-dependent di- and tricarboxylate transporter, NaCT, is not responsible for the uptake of D-, L-2-hydroxyglutarate and 3-hydroxyglutarate into neurons
por: Brauburger, Katja, et al.
Publicado: (2011)